Modification of Intestinal Microbiota and Its Consequences for Innate Immune Response in the Pathogenesis of Campylobacteriosis by Wycliffe Omurwa Masanta et al.
Hindawi Publishing Corporation
Clinical and Developmental Immunology
Volume 2013, Article ID 526860, 10 pages
http://dx.doi.org/10.1155/2013/526860
Review Article
Modification of Intestinal Microbiota and Its
Consequences for Innate Immune Response in
the Pathogenesis of Campylobacteriosis
Wycliffe Omurwa Masanta,
1,2 Markus M. Heimesaat,
3 Stefan Bereswill,
3
Abdul Malik Tareen,
1 Raimond Lugert,
1 Uwe Groß,
1 and Andreas E. Zautner
1,2
1 UMG-Labor, Institut f¨ ur Medizinische Mikrobiologie, Universit¨ atsmedizin G¨ ottingen, Kreuzbergring 57,
37075 G¨ ottingen, Germany
2UMG-Labor, Institut f¨ ur Klinische Chemie/Zentrallabor, Universit¨ atsmedizin G¨ ottingen, 37075 G¨ ottingen, Germany
3Institut f¨ ur Mikrobiologie und Hygiene, Charit´ e—Universit¨ atsmedizin Berlin, 12203 Berlin, Germany
Correspondence should be addressed to Andreas E. Zautner; azautne@gwdg.de
Received 22 June 2013; Revised 1 October 2013; Accepted 8 October 2013
Academic Editor: Bartholomew Akanmori
Copyright © 2013 Wycliffe Omurwa Masanta et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Campylobacter jejuni is the leading cause of bacterial food-borne gastroenteritis in the world, and thus one of the most important
public health concerns. The initial stage in its pathogenesis after ingestion is to overcome colonization resistancethat is maintained
by the human intestinal microbiota. But how it overcomes colonization resistance is unknown. Recently developed humanized
gnotobiotic mouse models have provided deeper insights into this initial stage and host’s immune response. These studies have
found that a fat-rich diet modifies the composition of the conventional intestinal microbiota by increasing the Firmicutes and
Proteobacteria loads while reducing the Actinobacteria and Bacteroidetes loads creating an imbalance that exposes the intestinal
epithelialcellstoadherence.Uponadherence,deoxycholicacidstimulatesC.jejunito synthesize Campylobacter invasion antigens,
which invade the epithelial cells. In response, NF-𝜅B triggers the maturation of dendritic cells. Chemokines produced by the
activated dendritic cells initiate the clearance of C. jejuni cells by inducing the actions of neutrophils, B-lymphocytes, and various
subsets of T-cells. This immune response causes inflammation. This review focuses on the progress that has been made on
understanding the relationship between intestinal microbiota shift, establishment of C. jejuni infection, and consequent immune
response.
1. Introduction
CampylobacterjejuniisaGram-negative,spiral-shaped,non-
spore forming, and highly motile bacterium that grows opti-
mallyundermicroaerophilicconditionsat42
∘C.Thegenome
of C. jejuni is roughly 1.6 to 1.7Mbp with a G+C ratio of
approximately 31% [1]. C. jejuni has a wide spectrum of hosts
ranging from wild birds, chicken, and turkey to mammals
such as cattle, swine, sheep, and humans and can also be
found in milk, meat, and stock water.
C. jejuni is a highly prevalent commensal bacterium in
allitshostsexceptforhumanscausingabacterialfood-borne
illnessknownascampylobacteriosis.Campylobacteriosishas
been found to be a usually self-limiting disease that is
characterized by symptoms such as fever, abdominal cramps,
bloody diarrhea, dizziness, and myalgia. However, in rare
cases campylobacteriosis may lead to postinfectious compli-
cationsliketheGuillain-Barr´ esyndrome(includingthemost
severe form: the Miller-Fisher syndrome), reactive arthritis
(Reiter’ssyndrome),postinfectiousirritablebowelsyndrome,
and potentially immunoproliferative small intestinal disease
[2,3].Epidemiologicalstudieshaveshownthatthebacterium
infects all age groups of different social-economic regions
all over the world, resulting in characteristic diarrhea. In
developed countries, the disease has a prevalence peak in
young adults and is characterized by bloody diarrhea with2 Clinical and Developmental Immunology
mucus. On the other hand, in developing countries the dis-
ease mainly affects children below the age of five manifesting
as watery diarrhea leading to exsiccosis and electrolyte loss
[4].TheincidenceofC.jejuniinfectionvariesthroughoutthe
world but remains to be a major cause of diarrheal disease in
both developed and developing countries. The major sources
of human infections have been found to be consumption of
cross-contaminated food, contaminated milk, milk products
and water, consumption of undercooked chicken, pig, and
beef as well as contact with a mammalian host (e.g., pets),
wild-birds, chicken, and bird droppings [2].
D u r i n gt h ec o u r s eo fi n f e c t i o nt h eb a c t e r i u mh a st op a s s
several obstacles and to survive in different environments.
After ingestion of at least 500 viable bacteria [5], C. jejuni
has to establish in the intestinal milieu, which is influential
by host antibacterial mechanisms like secretion of bile acids
into the intestines and the intestinal microbiota.
It is hypothesized that the prevailing conditions (indi-
vidually or collectively) within the human digestive system
stimulate C. jejuni to synthesize virulence-associated factors
that are involved in the development of campylobacteriosis
[6, 7]. To support this hypothesis, studies on the mechanisms
facilitatingcolonizationandsurvivalofC.jejuniinthehuman
gu tasw ellaso nadher ence,en try ,end ura nce,a ndr eplica tio n
of the pathogen in human epithelial cells have received a lot
of attention in the past.
Nowadays, distinct factors involved in the disruption of
physiological colonization resistance maintained by com-
mensal intestinal bacteria [8], are of increasing interest.
2. Intestinal Microbiota and
Colonization Resistance
2.1. Intestinal Microbiota. The human digestive tract houses
a plethora of commensal microbial, fungal, and protozoan
species as well as viruses that are collectively referred to as
intestinal“microbiota”.Theintestinalmicrobiotaiscomposed
of bacteria from different phyla, bacteriophages, and a single
phylum of archaea, yeast, and filamentous fungi [9]. The
different phyla of bacteria in the microbiota are consistent
from childhood to adulthood but the species distribution is
notconstantduetovariousfactors.Betweenthedeliverytime
of a child and an age of 5 years, the intestinal microbiota
is determined by mode of delivery, breast feeding and other
types of feeding, gestational age, infant hospitalization, and
antibiotic treatment(s) [10, 11]. During this stage of life,
bacteria of the following genera are dominant: Bifidobac-
terium, Bacteroides, Lactobacillus, Escherichia, Klebsiella,a n d
Clostridium.I na d u l ta g ea n di nc h i l d r e na b o v e6y e a r s ,
the composition of intestinal microbiota is complex with
bacterial genera varying considerably among individuals due
to age, genetics, health status, geographical location, stress,
antibiotic exposure, and diet [10, 12]. In spite of the existence
of various factors that influence the composition of bacterial
genera in the intestines among various adults, the following
bacteriaphyla,namely,Bacteroidetes,Firmicutes,Proteobac-
teria, Actinobacteria, Fusobacteria, Verrucomicrobia, and
Tenericutes, have been found to make up the adult intestinal
microbiota with Bacteroidetes and Firmicutes being more
dominant as compared to Proteobacteria, Actinobacteria,
Fusobacteria, Verrucomicrobia, and Tenericutes [9, 13]. In
additiontothebacterialspeciesdifferencesexistinginmicro-
biota of children ≤5 years, children >6y e a r s ,a n da d u l t s ,t h e
bacterial loads in distinct regions of the intestinal tract vary
considerably. For example, stomach and duodenum harbor
a rather low jejunum and ileum a relatively intermediate
and the distal colon by far the highest bacterial load within
the gastrointestinal tract [14]. Importantly, the human host
benefits from the intestinal microbiota by (i) fermentation
of indigestible complex carbohydrates to absorbable short-
chain fatty acids (SCFAs), (ii) detoxification of potentially
harmful substances such as bile acids and bilirubin, (iii)
providing an important layer of defense against invasion
by pathogenic microorganisms also known as colonization
resistance, and (iv) playing an important role in the proper
development of immune system (see [15, 16] for detailed
reviews).
2.2. Colonization Resistance. Colonization resistance is a
physiologicalphenomenonexertedbythecommensalintesti-
nal microbiota, which deter pathogens from causing infec-
tions.In1950Bohnhoffandcoworkersobservedthattreating
mice with antibiotics prior to Salmonella enterica infection
resulted in reduction of pathogen loads required to cause
S. enterica associated infection [17]. Since then several stud-
ies have been carried out to understand the underlying
mechanisms of colonization resistance in humans. So far,
murine in vivo studies revealed that intestinal microbiota
accomplish colonization resistance by (i) blocking pathogens
fromattachingtotheirtargetsites[18],(ii)depletingnutrients
hence preventing pathogens from colonizing the intestines,
and (iii) SCFAs and particularly bacteriocins produced as a
resultofintestinalmicrobiotametabolicactivities,whichpre-
vent pathogenic bacteria from expressing distinct virulence
genes. For example, butyrate has been shown to prevent S.
enterica from expressing its type III secretion system (T3SS)
a n dt h u sw e a k e n si t sa b i l i t yt oi n v a d ee p i t h e l i a lc e l l s[ 19].
Further, (iv) organic acids generated by intestinal microbiota
metabolic activities alter intraluminal pH to levels that
cannot support growth and replication of pathogens such as
Salmonellaspp.andEscherichiacoliO157[20],and(v)intesti-
nalmicrobiotautilizemostoxygenavailableinthegutleading
to the creation of an anaerobic and capnophilic environment
that affects the ability of some enteric pathogens to colonize
the gut [21]. However, the role of archaea,y e a s t ,fi l a m e n t o u s
fungi, protozoan, and helminthic parasites as well as viruses
including bacteriophages in colonization resistance is not
fully understood so far.
3. Products of Intestinal Microbiota
Metabolism Affecting C. jejuni
The colonic microbiota utilizes dietary compounds, which
remain undigested and/or unabsorbed in the small intestine
as growth and replication substrates. This process leads to
formation of a number of metabolic products that (i) help
microbiotic bacteria species to grow and replicate, (ii) are
beneficial but, (iii) have also been found to be harmful toClinical and Developmental Immunology 3
the human host (see [14, 22] for detailed reviews). Inter-
estingly, metabolic end products derived from the intestinal
microbiota aid C. jejuni, for instance, to colonize the human
gut and invasion of epithelia cells in the following ways.
(a) Short Chain Fatty Acids as a Carbon Source.L i k eo t h e r
undigested food compounds, complex dietary carbohydrates
a n dp r o t e i n st h a tr e m a i nu n d i g e s t e di nt h eh u m a ns m a l l
intestinal lumen are transported to the large intestinal tract
for further digestion and absorption. The large intestine of a
healthy human adult mainly harbors bacteria of the follow-
ing phyla: Bacteroidetes, Firmicutes, Actinobacteria, Verru-
comicrobia, and Proteobacteria. These bacteria are capable
of anaerobically breaking polysaccharides, oligosaccharides,
proteins, peptides, and glycoproteins down to form SCFAs,
principally, acetate, formate, lactate, butyrate, propionate,
valerate, caproate, and succinate [23]. However, the SCFA
yield depends on the availability of carbon sources within
the large intestine. In conditions of higher carbon availability
(“excess”), the major SCFAs generated are acetate and for-
mate, whereas in situations of low carbon availability, lactate
and acetate are the major SCFA generated [24]. Interestingly,
previous reports showed that C. jejuni utilizes acetate and
lactate as carbon sources [25, 26]. Furthermore, lactate and
acetate consequently contribute to colonization of C. jejuni
in human gut.
(b) Signaling the Synthesis of Virulence-Associated Factors. C.
jejuni has been shown to utilize the end products of the gut
microbiotical biotransformation of bile salts and it has been
demonstrated that bile salts function as induction signals for
synthesisandsecretionofsomeC.jejunivirulence-associated
factors via the flagellar type III homologue secretion system
[6].
Bile salts are initially synthesized in the human liver.
Cholic acid (CA; 3𝗼,7 𝗼,1 2 𝗼-trihydroxy-5𝗽-cholan-24-oic
acid) and chenodesoxycholic acid (CDCA; 3𝗼,7 𝗼-dihy-
droxy-5𝗽-cholan-24-oic acid) are the only bile salts that are
synthesized by hepatocytes. Hence, they are named primary
bile salts. Upon synthesis, these bile salts circulate in a
processknownasenterohepaticcirculation,inwhichtheyare
secreted into the gallbladder, then into the duodenum, from
w h i c ht h e yr e a c hj e j u n u ma n di l e u ma sw e l la si nt h el a r g e
intestine. There they are reabsorbed by active transport into
t h eb l o o ds y s t e ma n dfi n a l l yt r a n s p o r t e dt ot h el i v e rf o r
resynthesis and subsequently released into the gallbladder
(again) [27, 28]. The unabsorbed bile salts are transported
along with other undigested products to the large intestine.
There reside anaerobic gut bacteria of the genera Lactobacil-
lus, Eubacterium, Bacteroides, Clostridium,a n dEscherichia,
which express different bile salt hydrolases. These transform
the unabsorbed bile salts by deconjugation and oxidation
of hydroxyl-groups at C-3, C-7, and C-12, as well as 7𝗼/𝗽-
dehydroxylation into their respective unconjugated free bile
acids commonly known as secondary bile acids [22]. Ridley
et al. used the term biotransformation to describe decon-
jugation, oxidation of hydroxyl-groups at C-3, C-7 and C-
12, and 7𝗼/𝗽-dehydroxylation of unabsorbed primary bile
salts [29]. During biotransformation, cholic acid (CA; 3𝗼,
7𝗼,1 2 𝗼-trihydroxy-5𝗽-cholan-24-oic acid) is transformed
into deoxycholic acid (DOC; 3𝗼,1 2 𝗼-dihydroxy-5𝗽-cholan-
24-oic acid) while chenodeoxycholic acid (CDCA; 3𝗼,7 𝗼-
dihydroxy-5𝗽-cholan-24-oic acid) is transformed into litho-
cholic acid (LCA; 3𝗼-hydroxy-5𝗽-cholan-24-oic acid) [29].
Human gut bacteria transform unabsorbed primary bile
salts to enhance their colonization of the human gut by
reducing the toxicity of the primary bile salts, to obtain
carbon, nitrogen, and sulfur and to generate substances
for cellular biosynthetic reactions and electron transport
phosphorylation [30–33].
Interestingly, various studies have found secondary bile
salts in particular DOC to induce the expression of genes
that encode for so-called Campylobacter invasion antigens
(Cia) that have been shown to play a pivotal role in the
invasion of epithelial cells and survival within the epithelial
cells [6, 7, 34]. A microarray study carried out by Malik-
Kale and coworkers in 2008 revealed that a total of 202 genes
in the C. jejuni strain F38011 were affected when C. jejuni
was cultured in media containing DOC [6]; in particular, 150
genes were up-, whereas 48 were downregulated [6].
These results amend earlier studies, which revealed
that C. jejuni synthesizes at least 14 additional proteins
upon cocultivation with cultured mammalian cells that are
not thermotolerance-associated [35, 36]. Furthermore, these
findingsunderlinepreviousexperiments,whichrevealedthat
C. jejuni synthesizes a number of proteins during growth
in rabbit ileal loops that are not expressed under standard
laboratory (in vitro) conditions [37]. The findings derived
from these three studies might support results obtained in a
recent study showing that eight proteins were excreted into
the medium when C. jejuni was cultured with INT 407 cells
orinINT407-conditionedmedium[38].TheCiaproteinsare
secreted via a flagellar type III homologue secretion system
[39]. The role of lithocholic acid in pathogenesis of C. jejuni
is unknown until now.
(c) Serving as Electron Acceptors for the C. jejuni Highly
Branched Electron Transport Chains.A sm e n t i o n e da b o v e ,
the bile salt metabolism of intestinal microbiota yields
fumarate as one of its end products. C. jejuni has been
shown to express a methylmenaquinol fumarate reductase
(Mfr) located in the periplasm, which utilizes, as the name
suggests, methylmenaquinol (mMKH2, Em,7 −124mV) in
fumaratereduction[40].ThisenzymeenablesC.jejunitouse
fumarateasanelectronacceptorinoxygenlimitedconditions
[41]. This and other oxygen-independent electron-transport
chains, namely, nitrate, nitrite, and trimethylamine-N-oxide
(TMAO) as well as dimethyl sulfoxide (DMSO), are believed
to contribute to C. jejuni’s unique ability to colonize different
environments [42].
4. Shifts in Intestinal Microbiota
Composition and C. jejuni Enteritis
Reduced bacterial phyla ratio numbers in the intestinal
microbiota of a healthy individual are accompanied by an
abrogated physiological colonization resistance facilitating
infection with pathogens. Furthermore, diseases such as type4 Clinical and Developmental Immunology
Table 1: Summary of altered bacteria ratios in named noninfectious diseases.
Noninfectious disease Names of bacteria altered References
Type 1 diabetes Decrease in Lactobacillus spp. [43]
Type 2 diabetes Increase in Bacillus spp. and Lactobacillus spp. [44]
Obesity Increase in Bacteroidetes
Decrease (to low numbers) in Bifidobacteria spp.
[49, 50]
Inflammatory bowel
disease (including Crohn’s
disease and ulcerative
colitis)
Increase in Enterobacteriaceae
Decrease in Bacteroidetes and certain Firmicutes
[46, 51]
Irritable bowel syndrome Twofold increase in Firmicutes compared to Bacteroidetes with increase in
Clostridia spp. and decrease in Bifidobacteria spp.
[47]
Celiac disease
Increase in Lactobacillus spp., Bacteroides spp., Staphylococcus spp., and E. coli.
In some cases levels of Bifidobacteria spp. increase, while there is reduction in
some cases.
In children, there is increase in Firmicutes and low levels of Bacteroidetes.
[48, 52–54]
1d i a b e t e s[ 43], type 2 diabetes [44], obesity [45], inflamma-
tory bowel disease (including Crohn’s disease and ulcerative
colitis)[46],irritablebowelsyndrome[47],andceliacdisease
[48] ,a m o n go t h e r s ,h a v eb e e ns h o w nt ob ea s s o c i a t e dw i t h
shifted microbiota composition. Table 1 provides a summary
o fa l t e r e db a c t e r i ap h y l ar a t i o si nt h er e s p e c t i v ed i s e a s e sa n d
disorders.
As aforementioned, several factors including genetics,
geographical location, diet, and antibiotic exposure, among
others, can affect intestinal colonization resistance. Most
recent studies have unequivocally revealed that the diet is
a primary factor causing disruption of the intestinal micro-
biota-mediated colonization resistance. Recently, a study was
carried out to compare the intestinal microbiota of children
a g ed1 – 6i naru r alA fri ca nvilla g es i t ua t edi na ne n vi r o n m e n t
that is still comparable to that of Neolithic subsistence
farmers with the intestinal microbiota of western European
children of the same age, consuming typical western diet.
The study revealed that Actinobacteria and Bacteroidetes
were abundant in the children living in the rural African
village, whereas Firmicutes and Proteobacteria were abun-
dant in the European children [55]. Furthermore, the relative
a b u n d a n c eo fF i r m i c u t e si nt h eE u r o p e a nc h i l d r e nc o h o r t
was twofold higher as compared to the children population
i nt h er u r a lA f r i c a nv i l l a g e .Prevotella, Xylanibacter,a n d
Treponema were exclusively present only in African children,
whereas Enterobacteriaceae that are commonly abundant in
European children were not detected in the rural African
children. These findings are well in line with an earlier
s t u d yb yT u r n b a u g ha n dc o w o r k e r s ,d e t e c t i n gi n c r e a s e d
bacterial abundance (levels) of two classes of the phylum
Firmicutes: (i) class Erysipelotrichi (Clostridium innocuum,
Eubacterium dolichum,a n dCatenibacterium mitsuokai)a n d
(ii) class Bacilli (mainly Enterococcus sp.). In addition, a
drastic reduction in bacteria levels of the phylum Bac-
teroidetes was assessed when humanized C57BL/6J mice,
initiallykeptonastandardlow-fat-plant-polysaccharide-rich
dietwereswitchedtoahigh-fat,high-sugarwesterndiet[56].
For a detailed review on how diet disrupts the intestinal
microbiota, refer to [57].
Interestingly, a diet-induced intestinal microbiota shift
was recently linked to susceptibility for C. jejuni infection
[58]. Gnotobiotic mice fed a human western-style diet for
six weeks displayed a microbiota composition more com-
p a r a b l et oh u m a n st h a nt oc o n v e n t i o n a lm i c ec o n t r o l s .I n
turn, these “humanized” mice were susceptible to C. jejuni
infection, whereas gnotobiotic mice that were fed standard
murine chow established a murine microbiota composition
accounting for colonization resistance against the pathogen-
like conventionally colonized controls [58]. A quantitative
survey of the bacterial species abundant in the colonic lumen
of the mice on human western-style diet, standard murine
diet, and gnotobiotic mice reconstituted with a complete
human microbiota revealed that western-style diet fed mice
harbored higher E. coli and Clostridium/Eubacterium spp.
countsandlowerEnterococcus and Lactobacillusspp.loadsas
compared to standard murine diet fed mice. This study may
support the observation that individuals consuming western
diet are more prone to C. jejuni infections as compared
to those on a rather low-fat plant polysaccharide-rich diet
[55]. The role of commensal E. coli in abrogating intestinal
colonization resistance against C. jejuni has been previously
shown by Haag et al. [59]. As long as the intestinal E. coli
loadsofadultmiceharboringaconventionalmicrobiotawere
artificially elevated by feeding a commensal murine E. coli
strainviathedrinkingwater,micecouldbestablyinfectedby
C. jejuni at high loads, whereas conventional control animals
c o u l dn o t .C u r r e n ta n df u t u r es t u d i e sw i l lf u r t h e rd i s s e c t
t h ei m p a c to fd i s t i n c tb a c t e r i a ls p e c i e sw i t h i nt h et r i a n g l e
relationshipofcommensalbacteria,intestinalpathogens,and
innate host responses [8, 59].
5. Stage Model for the
Pathogenesis of C. jejuni
After overcoming the intestinal microbiota barrier located
on and within the intestinal mucin layer, C. jejuni has to
pass the mucosal epithelial barrier. Although not all C.
jejuni v i r u l e n c e - a s s o c i a t e df a c t o r sa r ek n o w nu pt on o w ,
t h ep r e s e n tfi n d i n g sh a v el e dt ot h ec o n s t r u c t i o no fas t a g eClinical and Developmental Immunology 5
model that attempts to explain to role of the associated
virulence determinants involved in the pathogenesis of C.
jejuni infection at this point. These stages are (1) motility
andchemotaxis,(2)adherenceto,translocation,andinvasion
of intestinal epithelial cells (IECs), (3) toxin production, (4)
survival in the epithelial cells, and (5) immune response and
inflammation of the intestinal epithelium [7, 60].
The expression of specific gene sets could be attributed to
thesedifferentstages:Firstly,theflaAandflaBgenes(flagellin
A & B that assemble flagella) and the regulatory gene cheY
(chemotaxis regulatory protein) are expressed. Flagella are
responsible for motility while cheY plays a role in chemotaxis
[61–63]. Secondly, the gene products of peb1A (periplasmic
bifunctional adhesin/ABC transporter aspartate/glutamate-
binding protein), cadF (cadherin F—outer membrane
fibronectin-binding protein), jlpA (surface lipoprotein), pflA
(paralysedflagellumprotein),ciaB,ciaC,ciaI(Campylobacter
invasion antigens B, C & I), and a cluster of lipoolig-
osaccharide (LOS) biosynthesis genes as well as pseudaminic
acid and legionaminic acid biosynthesis genes are synthe-
sized. They play a distinct role in adhesion and invasion
[7, 38, 64–69].
Thirdly,thegeneproductsof cdtA,cdtB, and cdtCa s sem-
ble the trimeric cytolethal distending toxin (CDT). CDT
contributes to the cytopathic effect associated with C. jejuni
infection [70]. Fourthly, the genes chuABCD, ceuBCDE,
cfrA,fhuABD,feoB,tonB-exbB-exbD,cft,andperRessentially
involved in iron homeostasis are expressed [29, 60, 71–75].
It should be noted, however, that in a subgroup of C. jejuni
isolates, that exhibit an extended amino acid metabolism
[76], the ferric uptake receptor cfrA is replaced by a protein
of unknown function and a second iron uptake transport
systemencodedbythegenescj0173c-cj0182ismissingcritical
components, such as cj0178 and tonB3,f o ri n s t a n c e[ 77, 78].
Fifthly, gene sodB (superoxide dismutase) and the genes
katA( c a t a l a s e )a n dahpC (alkyl hydroperoxide reductase)
contributing to superoxide stress defense and peroxide stress
defense,respectively,areexpressed[79–81].Finally,thegenes
groES (cochaperonin), groEL (chaperone), dnaJ(chaperone),
dnaK (chaperone), and clpB (ATP-dependent Clp protease
ATP-binding subunit) that play a role in thermotolerance
are expressed [36, 82–84]. It has been shown that C. jejuni
changes its respiration mode to fumarate respiration and
undergoes metabolic downshift in order to survive in mam-
malian cells [33].
6. C. jejuni Induced Innate and
Adaptive Immune Responses in
the Gastrointestinal Tract
The human gastrointestinal tract is endowed with a complex
immune system that is made up of cells, tissues, and immune
effector molecules constantly and efficiently communicating
with each other in order to eliminate invading microbial
pathogens.Asdiscussedabove,ashiftintheintestinalmicro-
biota composition leaves the intestinal epithelial cells (IECs)
vulnerable to invasion by C. jejuni consequently activating
boththeinnateandadaptiveimmunesystem[85]. Themajor
siteofbacteriamediatedinflammationandtissuedestruction
i sl o c a t e di nt h ec o l o n ,b u tt h e r ei se v i d e n c es h o w i n gt h a t
the mucosal immune responses include the ileum because C.
jejuni is transported across the epithelial barrier via ileal M-
cells [86].
Uponadhesionandinvasionofthecolonicepithelium,C.
jejuniinducesIL-8secretion,whichtosomeextentisinitiated
by the cytolethal distending toxin (CDT) [87]. The IL-8
responseistheinitialtriggerforacutemucosalinflammation
characterized by neutrophil infiltration and macrophage
activation, as well as proliferation of T- and B-lymphocytes.
Besides these immune cell aggregates immunopathological
features observed in colonic biopsies of infected patients
include apoptotic crypt drop-outs, microabscesses, and focal
ulcerations [88, 89]. The corresponding IgA and IgG anti-
bodies produced by mature B-cells against C. jejuni are
considered to contribute to long-term protection against
reinfection, but they might be detrimental when cross-
reacting with gangliosides in neurons which in turn results
in neurological sequelae such as GBS in about 1 out of 900
infected patients [90].
C. jejuni i n d u c e di n n a t ei m m u n er e s p o n s e sa r ei n i -
tiated by binding of bacterial cell wall compounds to
nucleotide-binding oligomerization domain (NOD) or to
Toll-like receptors (TLRs). At the cellular level adhering and
invading C. jejuni are detected by Toll-like-receptor 4 and
NOD1/CARD4,respectively.Innateimmunesignalingresults
in the activation of nuclear factor kappa B (NF-𝜅B) [91].
Further, NF-𝜅B stimulates production of various cytokines,
which in turn mediate maturation of dendritic cells (DCs)
into antigen presenting cells (APCs) and shape subsequent
B- andT-cell responses (Table 2 providesa summaryofthese
cytokines), whereas the activation of M𝜑-phagocytic cells,
monocytes,andneutrophilsfinallyleadstodirectelimination
ofC.jejuni[92–94].Withinthisscenario,human𝗽-defensins
h a v eb e e ns h o w nt oa t t a c kC. jejuni by rupturing the cell
membrane [95] .W h i l et h er o l eo fB - c e l l sa n dt h er o l eo f
the antibody responses in GBS on one hand and protection
against disease on the other is well understood [90], innate
immunity of campylobacteriosis and corresponding T-cell
responsesawaitfurtherinvestigationandarethusinthefocus
of current and ongoing research. The lipooligosaccharide
(LOS)ofC.jejuniandthecorrespondinginna tereceptortoll-
like-receptor(TLR)4wereshowntobeofpivotalimportance
for induction and progression of experimental [96]a n d
human campylobacteriosis [97]. Notably, the LOS structure
ofC.jejuniishighlyvariableanditwasshownthatdecoration
of LOS with sialic acid residues aggravates the inflammatory
responseandtheoutcomeofhumancampylobacteriosis[97].
The elevated pathogenic potential of C. jejuni strains with
sialylated LOS (subtypes A, B, and C) is explained by the
increased binding of sialylated LOS to TLR-4 [98, 99]. The
resulting hyper-activation of TLR-4 signaling further drives
ulcerativeenteritis,bloodydiarrhea,fever,andpostinfectious
sequelae including GBS [97]. The important role of TLR-4
signaling in C. jejuni immunopathology was confirmed in
murine models of disease [87, 90] and corresponding results
demonstrate that LOS is a key virulence factor of C. jejuni.
Besides TLR-4, other TLRs such as TLR-2 and TLR-5 play6 Clinical and Developmental Immunology
Table 2: Cytokines induced in C. jejuni infections.
Cytokines Possible function References
Chemokines: CC families: MIP-1𝗼, MIP-1𝗽,
RANTES, and MCP-1
They act as chemoattractant agents for monocytes and
T-lymphocytes.
[92]
Chemokines: CXC families: GRO-𝗼,
GRO-𝗾,I P - 1 0 ,a n dM I G
GRO-𝗼 and GRO-𝗾 attract neutrophils to sites of inflammation.
IP-10 and MIG promote the chemotaxis of monocytes and activated
T-lymphocytes.
[101]
Interleukins: IL-1B, IL-6, IL-8, IL-10, IL-12,
IL-17A, IL-17F, IL-22, and IL-23
These chemoattractants and immune cells activators initiate Th1 and
Th17 response. IL-5 and IL-6 activate STAT3. IL-22 maintains
epithelial cell function and activation of macrophages.
[69, 93, 96, 100, 102, 103]
Interferon-gamma (IFN-𝗾) [59, 69, 86, 93]
T u m o rn e c r o s i sf a c t o r - a l p h a( T N F - 𝗼) Plays a major role in production of IL-1 and IL-6 [86, 93]
Nuclear factor kappa-light-chain-enhancer
(NF-𝜅B) signal transducer and activator of
transcription 3 (STAT3)
Stimulates production of chemokines
limits host inflammatory response in the gut
[86, 92, 104, 105]
only a minor role in C. jejuni enteritis [90] indicating that C.
jejuni flagellin and lipoproteins are not crucial for activation
of the immune system [100].
The C. jejuni induced adaptive T-cell responses in the
intestines have been recently dissected in an elegant study
using ex vivo infected explants of human colon tissue [69].
In these biopsies C. jejuni reached the subepithelial com-
partments following adhesion and invasion of IECs. The
direct contact of the invading bacteria with neutrophils,
macrophages, and dendritic cells initiated Th1 and responses
characterized by the release of IFN-𝗾,I L - 1 𝗽,I L - 1 2 ,a n d
IL-6 [69] .I n c r e a s e dI L - 1 2a n dI L - 2 3l e v e l si nt h e s ea r t i fi -
cially infected biopsies were indicative of DC activation and
maturation, which is subsequently driving the response of
distinct Th17 cell subsets. Elevated numbers of Th17, Th1,
and Th17/Th1 double-positive cells in the ex vivo infected
biopsies were well in line with increased concentrations of
IL-22 and IL-17 which finally orchestrate the eradication of
the pathogen by induction of innate responses and defensin
production in the epithelium [69].
7. Recent Advances in
Developing Murine Models Mimicking
Human Campylobacteriosis
A l t h o u g hh u m a nc a m p y l o b a c t e r i o s i si so fg l o b a li m p o r -
tance, efforts geared towards understanding the underlying
molecular mechanisms of C. jejuni infection and associated
immune responses have not yielded profound insights due
to the lack of appropriate in vivo models. Chicken, newborn
piglets, weanling ferrets, gnotobiotic canine pups, primates,
andisolator-raisedgerm-freemicemodelshavebeenmoreor
less successfully used for studying the interaction between C.
jejuni a n dt h eh u m a nh o s t .N u m e r o u ss t u d i e sa r eh a m p e r e d
for several reasons; a detailed discussion, however, is beyond
the scope of this review. In a nutshell, all mentioned models
are expensive to construct and maintain, some are challeng-
ing in handling and availability, or lack of reproducibility
[106]. Most murine models overcome these shortcomings,
but suffer from sporadic colonization and/or absence of
clinical disease manifestation [107]. Recently, combinations
o fv a r i o u ss t r a t e g i e sh a v eb e e nu s e dt oc o n s t r u c tg n o t o -
biotic mice (GB), gnotobiotic humanized flora-associated
mice (hfa), and gnotobiotic murine flora-associated mice
(mfa) models [94]. The GB mice model was developed by
treating 10- to 12-week old mice with a quintuple antibiotic
regimen(consistingofampicillin,vancomycin,ciprofloxacin,
imipenem, and metronidazole) for six to eight weeks [108].
These gnotobiotic mice had been raised and housed under
regular conditions and exhibited a fully developed immune
system as opposed to isolator-raised germfree animals. Hfa
mice and mfa mice were then generated by peroral recolo-
nization of GB mice with complex human or murine micro-
biota, respectively. While mfa and conventional control mice
e x pe lth epa th o g e nw i th i naf ewd a y spo s ti n f ecti o n ,h f am i c e
are highly susceptible to C. jejuni infection and harbor the
pathogenathighloads,furtherunderliningthatcolonization
resistanceagainst(andsusceptibilityfor)intestinalpathogens
such as C. jejuni is due to the distinct host microbiota
composition. Upon stable infection, GB and hfa mice display
C. jejuni induced immunopathological features as seen in
humans such as proinflammatory immune responses in the
intestinal tract accompanied by significant apoptosis of the
colonic epithelial cells, whereas severe clinical campylobac-
teriosis symptoms such as bloody diarrhea are lacking. In the
following, Haag et al. showed that conventionally colonized
infant mice infected with C. jejuni right after weaning at the
age of three weeks developed self-limiting acute ulcerative
enterocolitis like in “classical” human campylobacteriosis
[109]. Interestingly, infant mice were susceptible to C. jejuni
infection—again—due to relatively high commensal E. coli
loads in their intestines by the age of three weeks, whereas
over time E. coli burdens decreased subsequently rendering
mice resistant to the pathogen [109]. Surprisingly, after the
acute phase of infection, infant mice were asymptomatic
carriers of C. jejuni over months. Strikingly, despite the
absence of clinical sequelae, distinct inflammatory responses
c o u l db ed e t e c t e dw i t h i nt h ei n t e s t i n a lt r a c tb u ta l s oa t
extraintestinal tissue sites such as liver, kidney, and the lungs
[109]. The infiltrating immune cells were mostly consisting
of CD3+ T-lymphocytes, and to a lesser extent of B220+ B-
lymphocytes. Thus, the infant C. jejuni infectionmodel is notClinical and Developmental Immunology 7
only mimicking “classical” self-limiting human campylobac-
teriosis,butmightalsobehelpingtounravelchronic(postin-
fectious) sequelae. Furthermore, gnotobiotic mice deficient
in TLR-2, TLR-4, TLR-9, MyD88, and IL-10 genes have
immensely contributed to our present understanding of the
i n n a t ea n da d a p t i v ei m m u n er e s p o n s e sa n da c c o m p a n y i n g
pro-inflammatoryresponsesfollowingC.jejuniinfection[94,
96]. Remarkably, within six days upon C. jejuni infection,
gnotobiotic IL-10-deficient mice developed severe ulcerative
enterocolitis,whichwasnotself-limitingandthusmimicking
severe human campylobacteriosis like in immunocompro-
mized (e.g., AIDS) patients [96]. Immunopathology was
significantly less pronounced, however, when gnotobiotic
IL-10−/− mice were additionally lacking the TLR-4 or, to
a lesser extent, TLR-2 gene. Thus, signaling of C. jejuni
lipooligosaccharide and lipoproteins play pivotal roles in the
immunopathology of campylobacteriosis [94, 96].
8. Concluding Remarks
Although the exact species composition of the intestinal
microbiota facilitating C. jejuni infection has not completely
u n r a v e l e dt od a t e ,t h er e c e n tp r o g r e s si ne s t a b l i s h i n ga
plethora of reliable murine models for different degrees of
C. jejuni infection such as the development of GB and hfa,
g e n e - k n o c k o u t ,a n dw e a n e di n f a n tm i c em o d e l sa r ea n dw i l l
be useful to further understand the underlying molecular
mechanismsofinteractionsbetweenC.jejuniand the human
intestinal microbiota as well as the human immune system.
Ultimately,thiscouldhelptosupportthedevelopmentofpre-
ventive or therapeutic strategies against C. jejuni-associated
diseaseforinstancethroughtheestablishmentofappropriate
diet schemes.
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